Early diagnosis and intervention is crucial for improving the quality of life of patients with Duchenne Muscular Dystrophy. However, emerging guidelines and therapeutic advances have brought about competency gaps in understanding mutation-specific treatments and more.

To address these gaps, PlatformQ Health, Parent Project Muscular Dystrophy, and the National Organization of Rare Disorders (NORD) produced a live, 60-minute CME session featuring a neurologist, pulmonologist, genetic counselor, and a patient advocate. Competence questions were posed prior to the event, immediately following, and two months afterwards.

Of the 385 learners who participated in the course, 64% reported a positive impact of the education on their clinical practice and 57% reported a positive impact on patient satisfaction.

PlatformQ Health’s own Carole Drexel, PhD, VP of Patient Education, will be presenting the results in-person at the World Muscle Society 2021 Virtual Congress. 

Have questions about the posters or want to learn more about how PlatformQ Health is delivering impactful education to HCPs and patients? Email us at digital@platformq.com